Executive Moves | Healthcare | BioTuesdays by Kilmer Lucas IR

Executive Moves

Roth promotes Yasmeen Rahimi to co-head biotech research

Roth Capital Partners promoted Yasmeen Rahimi, managing director and senior research analyst, to the position of co-head of biotechnology research.

March 28, 2019

Executive Moves

BriaCell Therapeutics names two biopharma experts to its board

BriaCell Therapeutics (TSV-V:BCT; OTCQB:BCTXF) appointed Dr. Rebecca Taub and Vaughn Embro-Pantalony as directors, and current board members Dr. Saeid Babaei, Rahoul Sharan, and Martin Schmieg have resigned, effective...

March 18, 2019

Executive Moves

C4 Therapeutics appoints Adam Crystal as CMO

C4 Therapeutics appointed a new CMO, Dr. Adam Crystal, to oversee clinical development of its pipeline of protein degrader-based therapeutics.

March 14, 2019

Executive Moves

BioSig appoints Barry Keenan as VP of engineering

BioSig Technologies (NASDAQ:BSGM) named Barry Keenan as VP of engineering to head up the company’s advanced product development.

March 6, 2019

Executive Moves

Roth names Tony Butler as head of biotech research

Roth Capital Partners appointed Charles “Tony” Butler as a managing director, senior research analyst and head of biotechnology research, and a partner.

February 21, 2019

Executive Moves

IntelGenx names Rodolphe Obeid as VP of operations

IntelGenx Technologies (TSXV:IGX; OTCQX:IGXT) appointed Dr. Rodolphe Obeid as VP of operations to oversee manufacturing, packaging, facilities and maintenance, production planning and supply chain management.

February 8, 2019

Executive Moves

Maxim names Mario Leite as a senior healthcare banker

Maxim Group expanded its healthcare investment-banking group with the appointment of Mario Leite as a managing director.

February 6, 2019

Executive Moves

BioSig appoints John Kowalski as VP of sales

BioSig Technologies (NASDAQ:BSGM) named John Kowalski as VP of sales to lead the commercial launch of the PURE EP signal acquisition and processing system, which is designed to improve the diagnosis and treatment of...

February 5, 2019

Executive Moves

Ocutrx Vision names Dr. Linda Lam as chief scientific and strategy officer

Closely-held Ocutrx Vision Technologies appointed Dr. Linda Lam as chief scientific and strategy officer to guide new technology development, and help align current and future R&D efforts, industry trends and growth...

January 16, 2019

Executive Moves

Prometic names Prof. Simon Best as interim CEO

Prometic Life Sciences (TSX:PLI; OTCQX:PFSCF) named Prof. Simon Best as interim CEO, effective immediately, succeeding Pierre Laurin, who has stepped down from his management and board responsibilities.

December 20, 2018

Executive Moves

Novavax promotes Jill Hoyt and Biegie Lee

Novavax (NASDAQ:NVAX) promoted Jill Hoyt to SVP of human resources and Biegie Lee to VP of information technology.

December 5, 2018

Executive Moves

Kelley Dealhoy joins Interface Biologics as VP of business development

Closely-held Interface Biologics (IBI) appointed Kelley Dealhoy to the position of VP business development.

December 4, 2018

Executive Moves

Richard Gormley joins HCW as vice chairman, president of capital markets

Richard Gormley has joined investment bank, H.C. Wainwright, as vice chairman and president of capital markets. Mr. Gormley has over 30 years of experience in the investment banking and capital markets business, having...

November 19, 2018

Executive Moves

Jerry Isaacson joins Roth as managing director and senior research analyst

Jerry Isaacson has joined Roth Capital Partners as a managing director and senior research analyst covering biotechnology and emerging therapeutics.

November 5, 2018

Executive Moves

Breath Therapeutics names Peter Shadday as chief commercial officer

Closely-held Breath Therapeutics appointed Peter Shadday as chief commercial officer to lead the company’s market access activities and product commercialization.

October 17, 2018

Executive Moves

ContraVir Pharma names biotech industry veteran, Robert Foster, as acting CEO

ContraVir Pharmaceuticals (NASDAQ:CTRV) appointed industry veteran, Robert Foster, as acting CEO, succeeding James Sapirstein.

October 3, 2018

Executive Moves

Imagin Medical names Chris Bleck to its board

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart:DPD2) named Chris Bleck to its board.

October 2, 2018

Executive Moves

Titan Pharma hires commercialization veteran, Dane Hallberg

Titan Pharmaceuticals (NASDAQ:TTNP) appointed Dane Hallberg to the newly created position of EVP and chief commercial officer, effective immediately, with responsibility for leading all of the company’s commercial...

October 2, 2018

Executive Moves

Ondine Biomedical names Cameron Lawrence as COO, CFO

Closely-held Ondine Biomedical appointed Cameron Lawrence as chief operating officer and chief financial officer.

October 1, 2018

Executive Moves

Raymond James names Dane Leone as a managing director in biotech research

Raymond James appointed Dane Leone as a managing director responsible for biotechnology coverage in the firm’s equity research department.

October 1, 2018

Executive Moves

3DS names Sherif Louis as CEO

3D Signatures (TSX:DXD) appointed Sherif Louis, as the company's chief executive officer.

September 25, 2018

Executive Moves

Vincent Gardès joins Truffle Capital’s biomed team as senior partner

Truffle Capital appointed Vincent Gardès to its biomed team as a senior partner, joining Dr. Philippe Pouletty, Alain Chevallier and Antoine Pau.

September 20, 2018

Subscribe